Skip to content

Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome: design and methods of a pilot randomized controlled trial.

Nazia Raja-Khan, Katrina Agito, Julie Shah, Christy M Stetter, Theresa S Gustafson, Holly Socolow, Allen R Kunselman, Diane K. Reibel, Richard S Legro

Contemporary Clinical Trials February 7, 2015 DOI: 10.1016/j.cct.2015.01.021 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot randomized controlled trial (design and methods paper) Peer reviewed
Sample size 86
Population Overweight or obese women with body mass index at least 25 kg/m2, including 31 women with polycystic ovary syndrome (PCOS)
Interventions Mindfulness-based stress reduction (MBSR) health education control
Duration 8-week intervention, 16-week follow-up
Measures Toronto Mindfulness Scale, blood pressure, blood glucose, quality of life, anxiety, depression
Topics Anxiety Depression Meditation
Keywords Humans Polycystic ovary syndrome Obesity Treatment outcome Pilot projects Stress, psychological Female Overweight Young adult Glucose
Registration NCT01464398
Key findings The paper describes the design of a pilot randomized controlled trial testing whether eight weeks of MBSR increases mindfulness and improves blood pressure, blood glucose, psychological distress, and quality of life in overweight or obese women with and without PCOS. The authors hypothesize that MBSR will produce favorable changes in these outcomes, which would support integrating MBSR with conventional medical care.

Abstract

Introduction: Mindfulness-based stress reduction (MBSR) may be beneficial for overweight/obese women, including women with polycystic ovary syndrome (PCOS), as it has been shown to reduce psychological distress and improve quality of life in other patient populations. Preliminary studies suggest that MBSR may also have salutary effects on blood pressure and blood glucose. This paper describes the design and methods of an ongoing pilot randomized controlled trial evaluating the feasibility and effects of MBSR in PCOS and non-PCOS women who are overweight or obese (NCT01464398). Methods and

Design: Eighty six (86) women with body mass index ≥ 25 kg/m(2), including 31 women with PCOS, have been randomized to 8 weeks of MBSR or health education control, and followed for 16 weeks. The primary outcome is mindfulness assessed with the Toronto Mindfulness Scale. Secondary outcomes include measures of blood pressure, blood glucose, quality of life, anxiety and depression.

Discussion: Our overall hypothesis is that MBSR will increase mindfulness and ultimately lead to favorable changes in blood pressure, blood glucose, psychological distress and quality of life in PCOS and non-PCOS women. This would support the integration of MBSR with conventional medical treatments to reduce psychological distress, cardiovascular disease and diabetes in PCOS and non-PCOS women who are overweight or obese.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics